Transfusion-dependent Alpha-Thalassemia
2 clinical trials · Condition
◉ Watch Transfusion-dependent Alpha-Thalassemia
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) (NCT04770779) | Agios Pharmaceuticals, Inc. | 2021-11-30 |
Track Transfusion-dependent Alpha-Thalassemia automatically
Every clearance here is in the API, with alerts when new ones post.